Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Poison-control centers are seeing a steady increase in calls related to weight-loss drugs, and the FDA shared a report ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...